Literature DB >> 10024605

Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1.

B G Stiles1, Y G Campbell, R M Castle, S A Grove.   

Abstract

This study describes a quick (<12 h) assay for detecting temperature decreases in BALB/c and C57BL/6 mice injected intraperitoneally (i.p. ) with staphylococcal enterotoxin A (SEA), SEB, or SEC3 or toxic shock syndrome toxin 1 and a potentiating dose of lipopolysaccharide (LPS). Toxin-specific antisera effectively neutralized the temperature fluctuations in this model. Orally administered SEA or SEB (50 microg/animal), with or without LPS, did not have an effect on temperature or lethality. Versus wild-type mice, transgenic knockout mice lacking the p55 receptor for tumor necrosis factor (TNF) or gamma interferon were protected against an i.p. challenge of SEA plus LPS. The p75 receptor for TNF and intercellular adhesion molecule 1 have a negligible role in this toxic shock model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024605      PMCID: PMC96491     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Superantigens produced by infectious pathogens: molecular mechanism of action and biological significance.

Authors:  B Fleischer
Journal:  Int J Clin Lab Res       Date:  1994

2.  Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice.

Authors:  S Florquin; Z Amraoui; D Abramowicz; M Goldman
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

Review 3.  Superantigen mediated shock: a cytokine release syndrome.

Authors:  T Miethke; C Wahl; D Regele; H Gaus; K Heeg; H Wagner
Journal:  Immunobiology       Date:  1993-11       Impact factor: 3.144

4.  Superantigen shock in mice with an inapparent viral infection.

Authors:  S R Sarawar; M A Blackman; P C Doherty
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

5.  Increased susceptibility of fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock.

Authors:  J D Mountz; T J Baker; D R Borcherding; H Bluethmann; T Zhou; C K Edwards
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

6.  Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.

Authors:  B G Stiles; S Bavari; T Krakauer; R G Ulrich
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D.

Authors:  J Y Chen; Y Qiao; J L Komisar; W B Baze; I C Hsu; J Tseng
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity.

Authors:  R D LeClaire; W Kell; S Bavari; T J Smith; R E Hunt
Journal:  Toxicology       Date:  1996-01-22       Impact factor: 4.221

10.  Lipopolysaccharide interferes with the induction of peripheral T cell death.

Authors:  A T Vella; J E McCormack; P S Linsley; J W Kappler; P Marrack
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

View more
  30 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.

Authors:  Teresa Krakauer; Marilyn Buckley
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 4.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

5.  Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.

Authors:  Melanie J Ragin; Nisebita Sahu; Avery August
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Xiphoid Surface Temperature Predicts Mortality in a Murine Model of Septic Shock.

Authors:  Orlando Laitano; David Van Steenbergen; Alex J Mattingly; Christian K Garcia; Gerard P Robinson; Kevin O Murray; Thomas L Clanton; Elizabeth A Nunamaker
Journal:  Shock       Date:  2018-08       Impact factor: 3.454

7.  Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.

Authors:  T Krakauer; B G Stiles
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

8.  An FtsZ-targeting prodrug with oral antistaphylococcal efficacy in vivo.

Authors:  Malvika Kaul; Lilly Mark; Yongzheng Zhang; Ajit K Parhi; Edmond J Lavoie; Daniel S Pilch
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Proinflammatory mediators of toxic shock and their correlation to lethality.

Authors:  Teresa Krakauer; Marilyn J Buckley; Diana Fisher
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

10.  Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.

Authors:  Eileen A Larkin; Bradley G Stiles; Robert G Ulrich
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.